Objective To observe the indexes of inflammation and anemia in maintenance hemodialysis patients with kidney transplant failure (KTF), and to provide clinical basis for improving the therapeutic effect. Methods Fifty-four maintenance hemodialysis patients with kidney transplant failure were included in Beijing Friendship Hospital and other fifty-four hemodialysis patients who had not undergone kidney transplantation were selected as controls. The demographic data of the patients, the results of blood cell counts, the dosage of erythropoietin (EPO) were recorded, and neutrophil to lymphocyte ratio(NLR), platelet to lymphocyte ratio(PLR), lymphocyte to monocyte ratio(LMR) and EPO resistance index was calculated, and the setup of patients’ databases for statistical analysis of the clinical data. Results There was no significant difference in age (t=-1.095, P=0.276), gender (χ2=0.983, P=0.321), and the duration of dialysis (t=1.634, P=0.105) between the two groups. There was significant difference in the number of eosinophils [(0.21±0.21)×109/L vs. (0.43±0.54)×109/L, t=-2.639, P=0.010], NLR [(4.14±1.92) vs. (3.47±1.18) , t=2.156, P=0.033], LMR [(2.78±0.80) vs. (3.51±1.18), t=-3.794, P=0.005] between the two groups. There was no statistical difference in the dosage of EPO between the two groups (Z=-1.611, P=0.107). The median ERI of the KTF group was 13.59 (7.21, 20.37), which was higher than that of the control group, which was 9.12 (5.75, 13.48), and the difference was statistically significant (Z=-2.515, P=0.012). The patients' ERI was positively correlated with PLR (r=0.247, P=0.010), and negatively correlated with LMR (r=-0.217, P=0.024), which was statistically significant. Conclusion Hemodialysis patients with kidney transplant failure have a hyper-inflammatory state, which may be one of the influence factors leading to EPO resistance.
LIU Xu
,
ZHANG Ai-Hua
,
DIAO Zong-Li
,
LIU Wen-Hu
. The relationship between inflammatory state and anemia in maintenance hemodialysis patients with renal allograft failure [J]. Chinese Journal of Blood Purification, 2022
, 21(08)
: 550
-553
.
DOI: 10.3969/j.issn.1671-4091.2022.08.002
[1] Yang C, Wang H, Zhao X, et al. CKD in China: Evolving Spectrum and Public Health Implications[J]. Am J Kidney Dis. 2020,76(2):258-264.
[2] 张胜男,贾丹,孙平辉,等.肾移植术后并发慢性移植肾失功影响因素分析[J].中华移植杂志(电子版).2021,15(3):147-151.
[3] 中华医学会器官移植学分会,中国医师协会器官移植医师分会.中国肾移植排斥反应临床诊疗指南(2016版)[J].器官移植.2016,7(5):332-338.
[4] 林锦雯,陈江华.再次肾移植受者和移植肾长期预后影响因素分析[J].中华移植杂志（电子版）.2019,13(2):109-113.
[5] Kang GW, Jang MH, Hwang EA, et al. Comparison of peritoneal dialysis and hemodialysis after kidney transplant failure[J]. Transplant Proc. 2013,45(8):2946-2948.
[6] Achinger SG, Ayus JC. When the source of inflammation is hiding in plain sight: Failed kidney transplants, clotted arteriovenous grafts, and central venous catheters[J]. Semin Dial. 2019,32(1):15-21.
[7] Valga F, Monzón T, Henriquez F, et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: a multicentre cross-sectional study[J]. Nefrologia (Engl Ed). 2020,40(3):320-327.
[8] Zhang J, Lu X, Wang S, et al. High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis[J]. Biomed Res Int.2021,2021:9958081.
[9] Xiang F, Chen R, Cao X, et al. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study[J]. Hemodial Int. 2018,22(1):82-92.
[10] Hildebrand S, Corbett R, Duncan N,et al. Increased prevalence of eosinophilia in a hemodialysis population: Longitudinal and case control studies[J]. Hemodial Int. 2016,20(3):414-420.
[11] de Oliveira Júnior WV, Sabino Ade P, Figueiredo RC, et al. Inflammation and poor response to treatment with erythropoietin in chronic kidney disease. J Bras Nefrol. 2015 Apr-Jun;37(2):255-263.
[12] López-Gómez JM, Pérez-Flores I, Jofré R, et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance[J]. J Am Soc Nephrol. 2004,15(9):2494-2501.
[13] Mehrotra A, Tan JA, Ames SA. "Out of Sight, Out of Mind": The Failed Renal Allograft as a Cause of ESA Resistance[J]. Semin Dial. 2015;28(5):530-532.
